HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuma Irie Selected Research

Biomarkers (Surrogate Marker)

11/2020The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takuma Irie Research Topics

Disease

10Neoplasms (Cancer)
10/2022 - 01/2019
3Lung Neoplasms (Lung Cancer)
10/2022 - 11/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
10/2021
1Microsatellite Instability
10/2021
1Hypoxia (Hypoxemia)
04/2009

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
01/2022 - 11/2020
2Neoplasm Antigens (Tumor Antigens)IBA
11/2021 - 01/2019
1ChromatinIBA
10/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1NivolumabIBA
01/2022
1CateninsIBA
11/2021
1Small Cytoplasmic RNAIBA
11/2021
1Calcibiotic Root Canal SealerIBA
10/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2021
1LigandsIBA
11/2020
1Programmed Cell Death 1 ReceptorIBA
11/2020
1Biomarkers (Surrogate Marker)IBA
11/2020
1Proteins (Proteins, Gene)FDA Link
04/2009

Therapy/Procedure

4Therapeutics
01/2022 - 11/2020
3Immunotherapy
10/2022 - 01/2019